Jay D. Amsterdam: The Paroxetine 352 Bipolar Study Ethical Conduct

10. Attachment M (Letter to the Office of Research Integrity – Lawyer’s

letter excerpt)

“DR. AMSTERDAM’S TIMELINE RE PUBLICATION OF PAXIL BIPOLAR STUDY 352 WITHOUT HIS KNOWLEDGE”

       Dr. Amsterdam contacted his immediate supervisor and department chairman, Dr. Dwight L. Evans about the matter. In a March 22,2001 email to Dr. Amsterdam, Dr. Evans stated that he had discussed the issue with Dr. Karl Rickels who was also a professor in the Department of Psychiatry at the University of Pennsylvania and Dr. Gyulai's direct supervisor. Dr. Evans assured Dr. Amsterdam that Dr. Rickels would be reviewing the matter and, once accomplished, he trusted there would be "an equitable outcome." (Attachment M.)

ATTACHMENT M

Sender: psych@mail.med.upenn.edu

Mailer: QUALCOMM Windows Eudora Light Version 3.0.3 (32)

Date: Thu, 22 Mar 2001 04:31:18 -0500

To: jamsterd@mail.med.upenn.edu

From: "Dr. Dwight L. Evans, MD" <psych@mail.med.upenn.edu>

Subject: SKB Study

Cc: krickels@mail.med.upenn.edu

Dear Jay,

I have discussed the SKB study at length with Karl Rickels. He will review and look into the entire matter as it relates to the work that you did here at Penn. Once this is accomplished, I trust there will be an equitable outcome.

Dwight

Dwight L. Evans, MD

Ruth Meltzer Professor and Chairman

Department of Psychiatry

University of Pennsylvania Health System

3 Blockley Hall

Philadelphia, PA 19104

215-662-2818

215-662-6911 Fax

Email: psych@mail.med.upenn.edu

October 7, 2021